Garry Menzel
Chief Executive Officer bij TCR2 THERAPEUTICS INC.
Vermogen: 541 818 $ op 29-02-2024
Profiel
Presently, Garry E.
Menzel occupies the position of Chief Executive Officer at TCR2 Therapeutics, Inc. He is also on the board of Epilepsy Therapy Project, Adaptimmune Therapeutics Plc, Stoke Therapeutics, Inc. and Black Diamond Therapeutics, Inc. and Member-National Board at Epilepsy Foundation and Principal at Royal College of Art.
In his past career Dr. Menzel held the position of Chief Operating Officer for Regulus Therapeutics, Inc., Chief Financial Officer at DaVita, Inc., Managing Director at The Goldman Sachs Group, Inc., Consultant at Bain & Co., Inc., Chief Strategy Officer at Axcella Health, Inc., Research Assistant at Smithkline Beecham Plc and Managing Director at Credit Suisse Group AG.
He received an undergraduate degree from Imperial College London, an MBA from Stanford Graduate School of Business and a doctorate from the University of Cambridge.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
16-05-2023 | 76 644 ( 0.15% ) | 394 333 $ | 29-02-2024 | |
10-07-2023 | 563 522 ( 0.10% ) | 147 485 $ | 29-02-2024 | |
STOKE THERAPEUTICS, INC.
-.--% | 01-09-2023 | 0 ( -.--% ) | - $ | 29-02-2024 |
Actieve functies van Garry Menzel
Bedrijven | Functie | Begin |
---|---|---|
TCR2 THERAPEUTICS INC. | Chief Executive Officer | 01-01-2016 |
BLACK DIAMOND THERAPEUTICS, INC. | Director/Board Member | 01-01-2014 |
STOKE THERAPEUTICS, INC. | Director/Board Member | 13-08-2020 |
ADAPTIMMUNE THERAPEUTICS PLC | Director/Board Member | 01-06-2023 |
Epilepsy Foundation
Epilepsy Foundation Miscellaneous Commercial ServicesCommercial Services Epilepsy Foundation provides welfare services. It offers therapies to stop seizures, wellness institute and legal issue services. The company was founded in 1967 and is headquartered in Landover, MD. | Corporate Officer/Principal | 01-01-2003 |
Epilepsy Therapy Project | Director/Board Member | - |
Royal College of Art | Corporate Officer/Principal | 17-03-2010 |
Eerdere bekende functies van Garry Menzel
Bedrijven | Functie | Einde |
---|---|---|
AXCA HEALPAR | Corporate Officer/Principal | 01-09-2016 |
DAVITA INC. | Director of Finance/CFO | 30-03-2015 |
░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░ ░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░ ░░░░░░░ ░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Opleiding van Garry Menzel
Imperial College London | Undergraduate Degree |
University of Cambridge | Doctorate Degree |
Stanford Graduate School of Business | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 7 |
---|---|
DAVITA INC. | Health Services |
THE GOLDMAN SACHS GROUP, INC. | Finance |
REGULUS THERAPEUTICS INC. | Health Technology |
AXCA HEALPAR | Health Technology |
STOKE THERAPEUTICS, INC. | Health Technology |
BLACK DIAMOND THERAPEUTICS, INC. | Health Technology |
ADAPTIMMUNE THERAPEUTICS PLC | Health Technology |
Bedrijven in privébezit | 7 |
---|---|
Smithkline Beecham Plc
Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK. | Health Technology |
Credit Suisse Group AG
Credit Suisse Group AG Investment Banks/BrokersFinance Credit Suisse Group AG is a holding company, which engages in the provision of financial services. It operates through the following four divisions: Wealth Management, Investment Bank, Swiss Bank and Asset Management and four geographic regions: Switzerland, Europe, the Middle East and Africa (EMEA), Asia Pacific, and Americas. The Wealth Management division offers comprehensive wealth management and investment solutions, tailored financing, and advisory services to ultra-high-net-worth (UHNW) and high net-worth (HNW) individuals and external asset managers. The Investment Bank division offers a broad range of financial products and services focused on client-driven businesses and also supports Credit Suisse’s Wealth Management division and its clients. The Swiss Bank division offers comprehensive advice and a wide range of financial solutions to private, corporate, and institutional clients in Switzerland. The Asset Management division offers investment solutions and services globally to a broad range of clients, including pension funds, governments, foundations and endowments, corporations, and individuals. The company was founded by Alfred Escher on July 5, 1856 and is headquartered in Zurich, Switzerland. | Finance |
Bain & Co., Inc.
Bain & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Bain & Co., Inc. provides management consulting services. It offers advisory services to the companies on their critical issues and opportunities: strategy, marketing, organization, operations, technology and mergers and acquisitions, across all industries and geographies. The company was founded in 1973 and is headquartered in Boston, MA. | Commercial Services |
Institute for Systems Biology
Institute for Systems Biology Miscellaneous Commercial ServicesCommercial Services Institute for Systems Biology operates as a nonprofit biomedical research organization. It develops a systems approach to characterize, predict, and manipulate state transitions in biological system. The company was founded by Leroy E. Hood, Ruedi Aebersold and Alan Aderem in 2000 and is headquartered in Seattle, WA. | Commercial Services |
Epilepsy Foundation
Epilepsy Foundation Miscellaneous Commercial ServicesCommercial Services Epilepsy Foundation provides welfare services. It offers therapies to stop seizures, wellness institute and legal issue services. The company was founded in 1967 and is headquartered in Landover, MD. | Commercial Services |
Epilepsy Therapy Project | |
TCR2 Therapeutics, Inc.
TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TCR2 Therapeutics, Inc. is a clinical-stage cell therapy company, which engages in the development of biological drugs and engineering T-cells for cancer therapy. It is also involved in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development. The company was founded by Patrick A. Baeuerle on May 29, 2015 and is headquartered in Cambridge, MA. | Health Technology |